Gadoteridol (BioDeep_00000033251)

   

human metabolite blood metabolite


代谢物信息卡片


3-methyl-16,19,24-trioxo-2,17,18,25-tetraoxa-5lambda5,8lambda5,11lambda5,14lambda5-tetraaza-1-gadolinaoctacyclo[9.6.3.3^{1,8}.2^{5,14}.0^{1,5}.0^{1,8}.0^{1,11}.0^{1,14}]pentacosan-2-ium-5,8,11,14-tetrakis(ylium)-1,1-diuide

化学式: C17H29GdN4O7 (559.1277253999999)
中文名称:
谱图信息: 最多检出来源 Homo sapiens(blood) 75%

分子结构信息

SMILES: CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]
InChI: /q

描述信息

Gadoteridol provides contrast enhancement of the brain, spine and surrounding tissues resulting in improved visualization (compared with unenhanced MRI) of lesions with abnormal vascularity or those thought to cause a disruption of the normal blood brain barrier. Gadoteridol can also be used for whole body contrast enhanced MRI including the head, neck, liver, breast, musculoskeletal system and soft tissue pathologies. n MRI, visualization of normal and pathological brain tissue depends in part on variations in the radiofrequency signal intensity that occur with changes in proton density, alteration of the T1, and variation in T2. When placed in a magnetic field, gadoteridol shortens the T1 relaxation time in tissues where it accumulates. Abnormal vascularity or disruption of the blood-brain barrier allows accumulation of gadoteridol in lesions such as neoplasms, abscesses, and subacute infarcts.
V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

同义名列表

18 个代谢物同义名

3-methyl-16,19,24-trioxo-2,17,18,25-tetraoxa-5lambda5,8lambda5,11lambda5,14lambda5-tetraaza-1-gadolinaoctacyclo[9.6.3.3^{1,8}.2^{5,14}.0^{1,5}.0^{1,8}.0^{1,11}.0^{1,14}]pentacosan-2-ium-5,8,11,14-tetrakis(ylium)-1,1-diuide; Gadolinium(6+) ion 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetic acid; Gadolinium 2,2,2-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid; Gadolinium 2,2,2-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate; Gadolinium 1,4,7-tris(carboxymethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane; Gadolinium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane; GD-Hydroxypropyl-D03a; Gadolinium-HP-do3a; Gadolinium HP-do3a; Gadoteridolum; GD-HP-Do 3a; Gadoteridol; GD-HP-D03a; GD-HP-DO3a; GD-HPDO3a; GdHPDO3a; Prohance; GD(DO3a)



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Enza Di Gregorio, Francesca Arena, Eliana Gianolio, Giuseppe Ferrauto, Silvio Aime. The interaction between iodinated X-ray contrast agents and macrocyclic GBCAs provides a signal enhancement in T1 -weighted MR images: Insights into the renal excretion pathways of Gd-HPDO3A and iodixanol in healthy mice. Magnetic resonance in medicine. 2022 07; 88(1):357-364. doi: 10.1002/mrm.29190. [PMID: 35253921]
  • Simona Bussi, Alessandra Coppo, Roberta Bonafè, Silvia Rossi, Sonia Colombo Serra, Laure Penard, Miles A Kirchin, Federico Maisano, Fabio Tedoldi. Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats. Journal of magnetic resonance imaging : JMRI. 2021 11; 54(5):1636-1644. doi: 10.1002/jmri.27693. [PMID: 33973290]
  • Masahiro Kobayashi, Swati Rane Levendovszky, Daniel S Hippe, Makoto Hasegawa, Nozomu Murata, Kiyoko Murata, Desiree A Marshall, Luis F Gonzalez-Cuyar, Kenneth R Maravilla. Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate. Radiology. 2021 09; 300(3):559-569. doi: 10.1148/radiol.2021204320. [PMID: 34128720]
  • Thomas Frenzel, Hannes-Friedrich Ulbrich, Hubertus Pietsch. The Macrocyclic Gadolinium-Based Contrast Agents Gadobutrol and Gadoteridol Show Similar Elimination Kinetics From the Brain After Repeated Intravenous Injections in Rabbits. Investigative radiology. 2021 06; 56(6):341-347. doi: 10.1097/rli.0000000000000749. [PMID: 33259443]
  • Gesine Knobloch, Thomas Frenzel, Hubertus Pietsch, Gregor Jost. Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions: A Comparative Animal Study. Investigative radiology. 2020 06; 55(6):367-373. doi: 10.1097/rli.0000000000000645. [PMID: 31985602]
  • Sean A Woolen, Prasad R Shankar, Joel J Gagnier, Mark P MacEachern, Lisa Singer, Matthew S Davenport. Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis. JAMA internal medicine. 2020 02; 180(2):223-230. doi: 10.1001/jamainternmed.2019.5284. [PMID: 31816007]
  • Enza Di Gregorio, Chiara Furlan, Sandra Atlante, Rachele Stefania, Eliana Gianolio, Silvio Aime. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging. Investigative radiology. 2020 01; 55(1):30-37. doi: 10.1097/rli.0000000000000608. [PMID: 31503081]
  • Andreas Naschberger, Pauline Juyoux, Jill von Velsen, Bernhard Rupp, Matthew W Bowler. Controlled dehydration, structural flexibility and gadolinium MRI contrast compound binding in the human plasma glycoprotein afamin. Acta crystallographica. Section D, Structural biology. 2019 Dec; 75(Pt 12):1071-1083. doi: 10.1107/s2059798319013500. [PMID: 31793901]
  • Aneesh Thakur, Fabrice Rose, Shaquib Rahman Ansari, Palle Koch, Veronica Martini, Sofie Lillelund Ovesen, Bjørn Quistorff, Samuel Maritim, Fahmeed Hyder, Peter Andersen, Dennis Christensen, Yuki Mori, Camilla Foged. Design of Gadoteridol-Loaded Cationic Liposomal Adjuvant CAF01 for MRI of Lung Deposition of Intrapulmonary Administered Particles. Molecular pharmaceutics. 2019 11; 16(11):4725-4737. doi: 10.1021/acs.molpharmaceut.9b00908. [PMID: 31539263]
  • Pavol Szomolanyi, Martin Rohrer, Thomas Frenzel, Iris M Noebauer-Huhmann, Gregor Jost, Jan Endrikat, Siegfried Trattnig, Hubertus Pietsch. Comparison of the Relaxivities of Macrocyclic Gadolinium-Based Contrast Agents in Human Plasma at 1.5, 3, and 7 T, and Blood at 3 T. Investigative radiology. 2019 09; 54(9):559-564. doi: 10.1097/rli.0000000000000577. [PMID: 31124800]
  • Alexander Radbruch, Henning Richter, Stefanie Fingerhut, Louise Francoise Martin, Anna Xia, Niklas Henze, Werner Paulus, Michael Sperling, Uwe Karst, Astrid Jeibmann. Gadolinium Deposition in the Brain in a Large Animal Model: Comparison of Linear and Macrocyclic Gadolinium-Based Contrast Agents. Investigative radiology. 2019 09; 54(9):531-536. doi: 10.1097/rli.0000000000000575. [PMID: 31261291]
  • Simona Bussi, Alessandra Coppo, Catherine Botteron, Valérie Fraimbault, Antonello Fanizzi, Elisa De Laurentiis, Sonia Colombo Serra, Miles A Kirchin, Fabio Tedoldi, Federico Maisano. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats. Journal of magnetic resonance imaging : JMRI. 2018 03; 47(3):746-752. doi: 10.1002/jmri.25822. [PMID: 28730643]
  • Joao Prola-Netto, Mark Woods, Victoria H J Roberts, Elinor L Sullivan, Christina Ann Miller, Antonio E Frias, Karen Y Oh. Gadolinium Chelate Safety in Pregnancy: Barely Detectable Gadolinium Levels in the Juvenile Nonhuman Primate after in Utero Exposure. Radiology. 2018 01; 286(1):122-128. doi: 10.1148/radiol.2017162534. [PMID: 28873045]
  • Robert J McDonald, Jennifer S McDonald, Daying Dai, Dana Schroeder, Mark E Jentoft, David L Murray, Ramanathan Kadirvel, Laurence J Eckel, David F Kallmes. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates. Radiology. 2017 11; 285(2):536-545. doi: 10.1148/radiol.2017161594. [PMID: 28640692]
  • Jessica Lohrke, Anna-Lena Frisk, Thomas Frenzel, Laura Schöckel, Martin Rosenbruch, Gregor Jost, Diana Constanze Lenhard, Martin A Sieber, Volker Nischwitz, Astrid Küppers, Hubertus Pietsch. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents. Investigative radiology. 2017 06; 52(6):324-333. doi: 10.1097/rli.0000000000000344. [PMID: 28323657]
  • Gregory J Wilson, Charles S Springer, Sarah Bastawrous, Jeffrey H Maki. Human whole blood 1 H2 O transverse relaxation with gadolinium-based contrast reagents: Magnetic susceptibility and transmembrane water exchange. Magnetic resonance in medicine. 2017 05; 77(5):2015-2027. doi: 10.1002/mrm.26284. [PMID: 27297589]
  • Richard C Semelka, Joana Ramalho, Ami Vakharia, Mamdoh AlObaidy, Lauren M Burke, Michael Jay, Miguel Ramalho. Gadolinium deposition disease: Initial description of a disease that has been around for a while. Magnetic resonance imaging. 2016 Dec; 34(10):1383-1390. doi: 10.1016/j.mri.2016.07.016. [PMID: 27530966]
  • Eric Lancelot. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion. Investigative radiology. 2016 11; 51(11):691-700. doi: 10.1097/rli.0000000000000280. [PMID: 27175546]
  • Nozomu Murata, Luis F Gonzalez-Cuyar, Kiyoko Murata, Corinne Fligner, Russell Dills, Daniel Hippe, Kenneth R Maravilla. Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function. Investigative radiology. 2016 07; 51(7):447-53. doi: 10.1097/rli.0000000000000252. [PMID: 26863577]
  • Jeff L Zhang, Chris C Conlin, Kristi Carlston, Luke Xie, Daniel Kim, Glen Morrell, Kathryn Morton, Vivian S Lee. Optimization of saturation-recovery dynamic contrast-enhanced MRI acquisition protocol: monte carlo simulation approach demonstrated with gadolinium MR renography. NMR in biomedicine. 2016 07; 29(7):969-77. doi: 10.1002/nbm.3553. [PMID: 27200499]
  • Gilles Soulez, Daniel C Bloomgarden, Neil M Rofsky, Martin P Smith, Hani H Abujudeh, Desiree E Morgan, Richard J Lichtenstein, Mark L Schiebler, Franz J Wippold, Craig Russo, Matthew J Kuhn, Kevin W Mennitt, Jeffrey H Maki, Alan Stolpen, Johnson Liou, Richard C Semelka, Miles A Kirchin, Ningyan Shen, Gianpaolo Pirovano, Alberto Spinazzi. Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol. AJR. American journal of roentgenology. 2015 Sep; 205(3):469-78. doi: 10.2214/ajr.14.14268. [PMID: 26295633]
  • Karen Y Oh, Victoria H J Roberts, Matthias C Schabel, Kevin L Grove, Mark Woods, Antonio E Frias. Gadolinium Chelate Contrast Material in Pregnancy: Fetal Biodistribution in the Nonhuman Primate. Radiology. 2015 Jul; 276(1):110-8. doi: 10.1148/radiol.15141488. [PMID: 25763829]
  • Catherine Do, Jeffrey L Barnes, Chunyan Tan, Brent Wagner. Type of MRI contrast, tissue gadolinium, and fibrosis. American journal of physiology. Renal physiology. 2014 Oct; 307(7):F844-55. doi: 10.1152/ajprenal.00379.2014. [PMID: 25100280]
  • Chang-Tong Yang, Prashant Chandrasekharan, Tao He, Zihan Poh, Anandhkumar Raju, Kai-Hsiang Chuang, Edward G Robins. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography. Biomaterials. 2014 Jan; 35(1):327-36. doi: 10.1016/j.biomaterials.2013.10.006. [PMID: 24138829]
  • Hiroto Sasamori, Makoto Saiki, Jumpei Suyama, Yoshimitsu Ohgiya, Masanori Hirose, Takehiko Gokan. Utility of apparent diffusion coefficients in the evaluation of solid renal tumors at 3T. Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine. 2014; 13(2):89-95. doi: 10.2463/mrms.2013-0038. [PMID: 24769634]
  • Mikel Sadek, Todd L Berland, Thomas S Maldonado, Caron B Rockman, Firas F Mussa, Mark A Adelman, Frank J Veith, Neal S Cayne. Use of preoperative magnetic resonance angiography and the Artis zeego fusion program to minimize contrast during endovascular repair of an iliac artery aneurysm. Annals of vascular surgery. 2014 Jan; 28(1):261.e1-5. doi: 10.1016/j.avsg.2013.07.001. [PMID: 24075152]
  • Lalit N Goswami, Lixin Ma, Peter J Kueffer, Satish S Jalisatgi, M Frederick Hawthorne. Synthesis and relaxivity studies of a DOTA-based nanomolecular chelator assembly supported by an icosahedral closo-B₁₂²⁻ core for MRI: a click chemistry approach. Molecules (Basel, Switzerland). 2013 Jul; 18(8):9034-48. doi: 10.3390/molecules18089034. [PMID: 23899836]
  • Juan Carlos Cutrin, Simonetta Geninatti Crich, Diana Burghelea, Walter Dastrù, Silvio Aime. Curcumin/Gd loaded apoferritin: a novel 'theranostic' agent to prevent hepatocellular damage in toxic induced acute hepatitis. Molecular pharmaceutics. 2013 May; 10(5):2079-85. doi: 10.1021/mp3006177. [PMID: 23548053]
  • Erik B Schelbert, Stephen M Testa, Christopher G Meier, William J Ceyrolles, Joshua E Levenson, Alexander J Blair, Peter Kellman, Bobby L Jones, Daniel R Ludwig, David Schwartzman, Sanjeev G Shroff, Timothy C Wong. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2011 Mar; 13(?):16. doi: 10.1186/1532-429x-13-16. [PMID: 21375743]
  • Mark A Perazella, Robert F Reilly. Imaging patients with kidney disease: how do we approach contrast-related toxicity?. The American journal of the medical sciences. 2011 Mar; 341(3):215-21. doi: 10.1097/maj.0b013e3181f016e6. [PMID: 21139495]
  • Ayele H Negussie, Pavel S Yarmolenko, Ari Partanen, Ashish Ranjan, Genevieve Jacobs, David Woods, Henry Bryant, David Thomasson, Mark W Dewhirst, Bradford J Wood, Matthew R Dreher. Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2011; 27(2):140-55. doi: 10.3109/02656736.2010.528140. [PMID: 21314334]
  • Thomas H Darrah, Jennifer J Prutsman-Pfeiffer, Robert J Poreda, M Ellen Campbell, Peter V Hauschka, Robyn E Hannigan. Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics : integrated biometal science. 2009 Nov; 1(6):479-88. doi: 10.1039/b905145g. [PMID: 21305156]
  • N P Blockley, L Jiang, A G Gardener, C N Ludman, S T Francis, P A Gowland. Field strength dependence of R1 and R2* relaxivities of human whole blood to ProHance, Vasovist, and deoxyhemoglobin. Magnetic resonance in medicine. 2008 Dec; 60(6):1313-20. doi: 10.1002/mrm.21792. [PMID: 19030165]
  • Mark A Perazella. How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?. Clinical journal of the American Society of Nephrology : CJASN. 2008 May; 3(3):649-51. doi: 10.2215/cjn.00670208. [PMID: 18385396]
  • Robert F Reilly. Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis. Clinical journal of the American Society of Nephrology : CJASN. 2008 May; 3(3):747-51. doi: 10.2215/cjn.05721207. [PMID: 18287249]
  • Garvan C Kane, Anthony W Stanson, Dita Kalnicka, David W Rosenthal, Christine U Lee, Stephen C Textor, Vesna D Garovic. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2008 Apr; 23(4):1233-40. doi: 10.1093/ndt/gfm725. [PMID: 18256017]
  • Thomas Jürgensen, Joachim Brossmann, Jörg Dieter Herrlinger. [Acute renal failure after gadolinium-containing contrast medium in preexisting chronic renal failure stage II]. Medizinische Klinik (Munich, Germany : 1983). 2007 Jun; 102(6):480-2. doi: 10.1007/s00063-007-1048-x. [PMID: 17571223]
  • Luigi Biancone, Simonetta Geninatti Crich, Vincenzo Cantaluppi, Giuseppe Mauriello Romanazzi, Simona Russo, Elisa Scalabrino, Giovanna Esposito, Federico Figliolini, Silvia Beltramo, Paolo Cavallo Perin, Giuseppe Paolo Segoloni, Silvio Aime, Giovanni Camussi. Magnetic resonance imaging of gadolinium-labeled pancreatic islets for experimental transplantation. NMR in biomedicine. 2007 Feb; 20(1):40-8. doi: 10.1002/nbm.1088. [PMID: 16986104]
  • Sophie Laurent, Luce Vander Elst, Robert N Muller. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast media & molecular imaging. 2006 May; 1(3):128-37. doi: 10.1002/cmmi.100. [PMID: 17193689]
  • Gregory W White, Wendell A Gibby, Michael F Tweedle. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Investigative radiology. 2006 Mar; 41(3):272-8. doi: 10.1097/01.rli.0000186569.32408.95. [PMID: 16481910]
  • Pasquina Marzola, Simona Ramponi, Elena Nicolato, Emanuela Lovati, Marco Sandri, Laura Calderan, Caterina Crescimanno, Flavia Merigo, Andrea Sbarbati, Adriana Grotti, Stefania Vultaggio, Friederich Cavagna, Vito Lorusso, Francesco Osculati. Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents. Investigative radiology. 2005 Jul; 40(7):421-9. doi: 10.1097/01.rli.0000167124.89782.db. [PMID: 15973133]
  • James H Wible, Michael R Hynes. Measurement of serum calcium concentration after administration of gadoversetamide in dogs. Radiology. 2004 Oct; 233(1):158-64. doi: 10.1148/radiol.2331031689. [PMID: 15454620]
  • Simonetta Geninatti Crich, Luigi Biancone, Vincenzo Cantaluppi, Debora Duò, G Esposito, Simona Russo, Giovanni Camussi, Silvio Aime. Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magnetic resonance in medicine. 2004 May; 51(5):938-44. doi: 10.1002/mrm.20072. [PMID: 15122675]
  • Wendell A Gibby, Krissa A Gibby, W Andrew Gibby. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy. Investigative radiology. 2004 Mar; 39(3):138-42. doi: 10.1097/01.rli.0000112789.57341.01. [PMID: 15076005]
  • Stephen J Gandy, Thiru A P Sudarshan, Declan G Sheppard, Lynsay C Allan, Trudy B McLeay, J Graeme Houston. Dynamic MRI contrast enhancement of renal cortex: a functional assessment of renovascular disease in patients with renal artery stenosis. Journal of magnetic resonance imaging : JMRI. 2003 Oct; 18(4):461-6. doi: 10.1002/jmri.10381. [PMID: 14508783]
  • M E Bartolini, J Pekar, D R Chettle, F McNeill, A Scott, J Sykes, F S Prato, G R Moran. An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis. Magnetic resonance imaging. 2003 Jun; 21(5):541-4. doi: 10.1016/s0730-725x(03)00081-x. [PMID: 12878264]
  • G Papachristopoulos, K G Bis, A N Shetty, M Ross, H Bagga, A Shirkhoda, G Laub. Breath-hold 3D MR angiography of the renal vasculature using a contrast-enhanced multiecho gradient-echo technique. Investigative radiology. 1999 Dec; 34(12):731-8. doi: 10.1097/00004424-199912000-00001. [PMID: 10587868]
  • J Ueda, T Furukawa, K Higashino, T Yamamoto, H Ujita, K Sakaguchi, Y Araki. Permeability of iodinated and MR contrast media through two types of hemodialysis membrane. European journal of radiology. 1999 Jul; 31(1):76-80. doi: 10.1016/s0720-048x(98)00090-4. [PMID: 10477103]
  • H Bagga, K G Bis. Contrast-enhanced MR angiography in the assessment of arteriovenous fistula after renal transplant biopsy. AJR. American journal of roentgenology. 1999 Jun; 172(6):1509-11. doi: 10.2214/ajr.172.6.10350281. [PMID: 10350281]
  • K Katagiri, S Okada, T Kumazaki, N Tsuboi. [Clearance of gadolinium contrast agent by hemodialysis: in vitro and clinical studies]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica. 1998 Nov; 58(13):739-44. doi: NULL. [PMID: 9866990]
  • J Gemery, B Idelson, S Reid, E K Yucel, H Pagan-Marin, S Ali, L Casserly. Acute renal failure after arteriography with a gadolinium-based contrast agent. AJR. American journal of roentgenology. 1998 Nov; 171(5):1277-8. doi: 10.2214/ajr.171.5.9798860. [PMID: 9798860]
  • A N Shetty, K G Bis, T G Vrachliotis, M Kirsch, A Shirkhoda, R Ellwood. Contrast-enhanced 3D MRA with centric ordering in k space: a preliminary clinical experience in imaging the abdominal aorta and renal and peripheral arterial vasculature. Journal of magnetic resonance imaging : JMRI. 1998 May; 8(3):603-15. doi: 10.1002/jmri.1880080314. [PMID: 9626875]
  • V M Runge, N M Williams. Investigation of MR contrast media utility with the VX-2 tumor model. Academic radiology. 1998 Apr; 5 Suppl 1(?):S34-6; discussion S45. doi: 10.1016/s1076-6332(98)80052-4. [PMID: 9561038]
  • P L Choyke, M M Walther, J R Wagner, W Rayford, J C Lyne, W M Linehan. Renal cancer: preoperative evaluation with dual-phase three-dimensional MR angiography. Radiology. 1997 Dec; 205(3):767-71. doi: 10.1148/radiology.205.3.9393533. [PMID: 9393533]
  • M F Tweedle, X Zhang, M Fernandez, P Wedeking, A D Nunn, H W Strauss. A noninvasive method for monitoring renal status at bedside. Investigative radiology. 1997 Dec; 32(12):802-5. doi: 10.1097/00004424-199712000-00011. [PMID: 9406021]
  • A Heuck, M Reiser. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)]. Der Internist. 1997 Dec; 38(12):1234-5. doi: NULL. [PMID: 9465330]
  • V M Runge, J F Timoney, N M Williams. Magnetic resonance imaging of experimental pyelonephritis in rabbits. Investigative radiology. 1997 Nov; 32(11):696-704. doi: 10.1097/00004424-199711000-00008. [PMID: 9387058]
  • V M Runge, J W Wells, N M Williams. Renal metastasis. Detection and characterization on enhanced magnetic resonance imaging using an animal model. Investigative radiology. 1997 Apr; 32(4):212-7. doi: 10.1097/00004424-199704000-00004. [PMID: 9101356]
  • J B Williams, V B Ho, J Wettlaufer, W H Bush. Gadoteridol as an alternative contrast agent for retrograde pyelography. Abdominal imaging. 1997 Mar; 22(2):233-4. doi: 10.1007/s002619900177. [PMID: 9013540]
  • D B Johnson, C A Lerner, M R Prince, S N Kazanjian, D L Narasimham, A B Leichtman, K J Cho. Gadolinium-enhanced magnetic resonance angiography of renal transplants. Magnetic resonance imaging. 1997; 15(1):13-20. doi: 10.1016/s0730-725x(96)00348-7. [PMID: 9084020]
  • K Yoshikawa, A Davies. Safety of ProHance in special populations. European radiology. 1997; 7 Suppl 5(?):246-50. doi: 10.1007/pl00006901. [PMID: 9370552]
  • N R Puttagunta, W A Gibby, G T Smith. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Investigative radiology. 1996 Dec; 31(12):739-42. doi: 10.1097/00004424-199612000-00001. [PMID: 8970874]
  • A Uchino, K Hasuo, A Mizushima, S Matsumoto, F Mihara, M Jimi, M Takahashi, K Masuda. Intracranial metastasis of renal cell carcinoma: MR imaging. Radiation medicine. 1996 Mar; 14(2):71-6. doi: NULL. [PMID: 8776768]
  • K Hui, G K Lee, F Zhang, K Li, L Cheung, W C Lineaweaver. Magnetic resonance imaging detection of vascular occlusion of a pedicled muscle flap. Microsurgery. 1996; 17(6):306-12. doi: 10.1002/(sici)1098-2752(1996)17:6<306::aid-micr4>3.0.co;2-f. [PMID: 9308714]
  • P L Choyke, M E Girton, E M Vaughan, J A Frank, H A Austin. Clearance of gadolinium chelates by hemodialysis: an in vitro study. Journal of magnetic resonance imaging : JMRI. 1995 Jul; 5(4):470-2. doi: 10.1002/jmri.1880050418. [PMID: 7549213]
  • M N Eakins, S M Eaton, R A Fisco, R J Hunt, C E Ita, T Katona, L M Owies, E Schramm, J W Sulner, C W Thompson. Physicochemical properties, pharmacokinetics, and biodistribution of gadoteridol injection in rats and dogs. Academic radiology. 1995 Jul; 2(7):584-91. doi: 10.1016/s1076-6332(05)80120-5. [PMID: 9419608]
  • M D Ogan, A C Reiss, E M Croze, E M Jagoda, B C Stouffer, S Mantha, H M Tsay, F J Yost, J I Tu. A specific radioimmunoassay for the measurement of gadoteridol, a contrast agent for magnetic resonance imaging in biological fluids. Journal of pharmaceutical sciences. 1993 May; 82(5):475-9. doi: 10.1002/jps.2600820509. [PMID: 8360824]
  • S M Eaton, P Wedeking, M F Tweedle, W C Eckelman. A multi-organ, axially distributed model of capillary permeability for a magnetic resonance imaging contrast agent. Journal of pharmaceutical sciences. 1993 May; 82(5):531-6. doi: 10.1002/jps.2600820520. [PMID: 8360832]
  • C Tilcock, Q F Ahkong, S H Koenig, R D Brown, M Davis, G Kabalka. The design of liposomal paramagnetic MR agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates. Magnetic resonance in medicine. 1992 Sep; 27(1):44-51. doi: 10.1002/mrm.1910270106. [PMID: 1435209]
  • S J McLachlan, S Eaton, D N De Simone. Pharmacokinetic behavior of gadoteridol injection. Investigative radiology. 1992 Aug; 27 Suppl 1(?):S12-5. doi: NULL. [PMID: 1506147]
  • J F Debatin, S N Nadel, L Gray, H S Friedman, P Trotter, B Hockenberger, W J Oakes. Phase III clinical evaluation of gadoteridol injection: experience in pediatric neuro-oncologic MR imaging. Pediatric radiology. 1992; 22(2):93-8. doi: 10.1007/bf02011303. [PMID: 1501959]
  • E C Unger, T A Fritz, C Tilcock, T E New. Clearance of liposomal gadolinium: in vivo decomplexation. Journal of magnetic resonance imaging : JMRI. 1991 Nov; 1(6):689-93. doi: 10.1002/jmri.1880010613. [PMID: 1823174]
  • V M Runge, D Y Gelblum, S Jacobson. Gd HP-DO3A--experimental evaluation in brain and renal MR. Magnetic resonance imaging. 1991; 9(1):79-87. doi: 10.1016/0730-725x(91)90100-z. [PMID: 2056855]
  • V M Runge, D Y Gelblum, M L Pacetti, F Carolan, G Heard. Gd-HP-DO3A in clinical MR imaging of the brain. Radiology. 1990 Nov; 177(2):393-400. doi: 10.1148/radiology.177.2.2217775. [PMID: 2217775]
  • V M Runge, D M Kaufman, M L Wood, L S Adelman, S Jacobson. Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology. 1989; 16(6):561-7. doi: 10.1016/0883-2897(89)90071-8. [PMID: 2606711]